TCT-701 Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry  by Buchanan, Gill et al.
TCT-701
Two Year Outcomes Following Unprotected Left Main Stenting with First- vs.
New-Generation Drug-Eluting Stents: The FINE Registry
Gill Buchanan1, Alaide Chieffo1, Chiara Bernelli1, Matteo Montorfano1,
Mauro Carlino1, Azeem Latib1, Filippo Figini1, Irene Franzoni1,
Santo Ferrarello2, Alfonso Ielasi1, Francesco Sacco1, Massimo Slavich1,
Alessandro Durante3, Alfredo Castelli1, Antonio Colombo1
1San Raffaele Scientific Institute, Milan, Italy, 2San Raffaele Scientific Institute,
Milano, Italy, 3San Raffaele scientific institute, Milano, Italy
Background: Minimal data exists regarding the use of new-generation new-generation
drug-eluting stent (DES) in the treatment of the unprotected left main (ULMCA) coronary
artery. Our aim was to assess 2-year clinical outcomes following first-vs. new-generation
DES implantation in patients undergoing intervention to the ULMCA.
Methods: All eligible patients from our 2-center prospective registry treated for ULMCA
with DES implantation from October 2006 to November 2010 were analyzed. The study
endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, target
vessel revascularization (TVR) and myocardial infarction (MI) at 2-years clinical
follow-up.
Results: A total of 186 patients were included: 93 (50.0%) with first- vs. 93 (50.0%) with
new-generation DES. There was a higher EuroSCORE in the new-generation group
(3.62.5 vs. 4.62.7; p0.007) however there was no difference in the SYNTAX scores
(25.211.3 vs. 26.59.2; p0.401). Distal disease was present in 81.7% in first- vs.
74.2% in new-generation (p0.216). No significant difference was observed in the
stenting technique; 2-stents were used respectively in 53.8% vs. 44.1% (p0.187).
Notably, intravascular ultrasound guidance was used more frequently with new-
generation (46.2% vs. 61.3%; p0.040). At 730.0 (interquartile range 365.5-1224.5) days
clinical follow-up, there was a statistical trend toward a benefit in MACE with
new-generation (31.2% vs. 19.6%; p0.070). With new-generation DES, there was a
significant reduction in TVR (23.7% vs. 12.0%; p0.038) and MI (4.3% vs. 0%;
p0.044) and a trend for less cardiac mortality (7.5% vs. 2.2%; p0.091) and TLR
(12.9% vs. 5.4%; p0.079). Furthermore, there were 4 cases of definite stent thrombosis
(ST) with first- vs. 0 in the new-generation group (p0.044).
Conclusions: In our study, new-generation DES had a trend for less MACE and
improved results with regards to MI, TVR and definite ST at 2-years clinical follow-up.
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Background: Treating left main (LM) bifurcation with stents is complex as LM trunks
have larger vessel references than others. Kissing balloon technique (KBT) and/or post
stent dilatation to LM trunks are needed in order to obtain adequate stent apposition in LM
trunks. The objective of this study was to investigate the impact of pre and post left main
dilatation on stent deformity during KBT of single stents with large LM bench testing
model.
Methods: In this test, a soft silicon model reenacted as a LM bifurcation vessel with
6.0mm proximal vessel reference. Styrene resin was used to surround this model (Shown
in Fig.1). After crossover stenting (3.5mm Nobori stent, Terumo Corporation, Tokyo) to
the main branch, two strategies of LM dilatation with a 6.0mm balloon was tested.
Strategy in model A was LM dilatation after KBT and not before, while strategy in model
B was LM dilatation before and not after KBT.
Results: In model A, post LM dilatation after KBT led to decrease the effect of KBT;
stent malaposition in the ostial of the side branch (Fig.2). On the other hand, in model B,
adequate stent apposition in the ostial of the side branch was obtained by KBT without
any unfavorable major distortion in the main or LM trunk.
Conclusions: LM dilatation before performing KBT is better especially when KBT is
performed in large LM bifurcation lesions. If LM dilatation after KBT is needed, checking
of stent distortion should be done afterward.
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Background: The aim of study is to compare the 5 years clinical outcome of drug-eluting
stent implantation in high-angled (70°) bifurcation (HAB) and lower-angled (70°)
bifurcation (LAB) lesion of unprotected left main coronary arteries.
Methods: A prospective analysis of 488 patients with LMT stenosis (374 HAB and 114
LAB) in five high volume Asian centers after successful stenting in LMT was performed.
LMT was treated with 5 strategies (single 195, mini-crush 116, culotte 89, T 47 cases,
crush 32 cases, kissing 9).
Results: At 5 years overall cardiac events of LAB (20.2%) were significantly lower than
HAB (29.1%) (p0.014).
Conclusions: Drug-eluting stent implantation in low-angled LMT bifurcation lesion
showed lesser incidence of cardiac events (death, myocardial infarction, CABG and PCI)
compared with high-angled LMT bifurcation lesion of unprotected left main coronary
arteries at 5 years clinical follow-up.
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